Skip to main content
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1987 Mar-Apr;60(2):187–193.

Neurochemical specificity of learning: dopamine and motor learning.

W J McEntee, R G Mair, P J Langlais
PMCID: PMC2590304  PMID: 2437709

Abstract

In previous reports of studies of patients with alcoholic Korsakoff's psychosis, data were presented showing significant correlations between neuropsychometric measures of amnesia and the CSF levels of the major brain metabolite of norepinephrine (NE), which was consistently reduced among a large group of experimental subjects. Dopamine (DA) metabolite concentrations in the CSF of this same patient population were also significantly lowered but to a lesser degree and less consistently than the NE metabolite. CSF levels of the DA metabolite did not correlate with any measures of amnesia but did significantly correlate with performance on the Digit-Symbol Substitution Test (DSST) of the Wechsler Adult Intelligence Scale (WAIS), which involves psychomotor skill learning. DSST performance did not correlate with CSF levels of the NE metabolite. These findings led to the hypothesis that the acquisition of motor learning skills is related to brain DA activity. In this study, we tested the hypothesis by correlating the ability of a group of Korsakoff patients to learn two different motor tasks (rotary pursuit and mirror tracing) with the concentrations of CSF metabolites of NE, DA, and serotonin. For both tasks, improvement in performance over three daily testing sessions significantly correlated only with the DA metabolite levels. The data are consistent with the hypothesis of a specific role for DA in motor learning.

Full text

PDF
189

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cohen N. J., Squire L. R. Preserved learning and retention of pattern-analyzing skill in amnesia: dissociation of knowing how and knowing that. Science. 1980 Oct 10;210(4466):207–210. doi: 10.1126/science.7414331. [DOI] [PubMed] [Google Scholar]
  2. Godwin-Austen R. B. Kantamaneni BD, Curzon G:Comparison of benefit from L-dopa in Parkinsonism with increase of amine metabolites in the CSF. J Neurol Neurosurg Psychiatry. 1971 Jun;34(3):219–223. doi: 10.1136/jnnp.34.3.219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Gottfries C. G., Gottfries I., Roos B. E. Homovanillic acid and 5-hydroxyindoleacetic acid in the cerebrospinal fluid of patients with senile dementia, presenile dementia and parkinsonism. J Neurochem. 1969 Sep;16(9):1341–1345. doi: 10.1111/j.1471-4159.1969.tb05984.x. [DOI] [PubMed] [Google Scholar]
  4. Hansch E. C., Syndulko K., Cohen S. N., Goldberg Z. I., Potvin A. R., Tourtellotte W. W. Cognition in Parkinson disease: an event-related potential perspective. Ann Neurol. 1982 Jun;11(6):599–607. doi: 10.1002/ana.410110608. [DOI] [PubMed] [Google Scholar]
  5. Langlais P. J., McEntee W. J., Bird E. D. Rapid liquid-chromatographic measurement of 3-methoxy-4-hydroxyphenylglycol and other monoamine metabolites in human cerebrospinal fluid. Clin Chem. 1980 May;26(6):786–789. [PubMed] [Google Scholar]
  6. Langlais P. J., Walsh F. X., Bird E. D., Levy H. L. Cerebrospinal fluid neurotransmitter metabolites in neurologically normal infants and children. Pediatrics. 1985 Mar;75(3):580–586. [PubMed] [Google Scholar]
  7. MANCALL E. L., MCENTEE W. J. ALTERATIONS OF THE CEREBELLAR CORTEX IN NUTRITIONAL ENCEPHALOPATHY. Neurology. 1965 Apr;15:303–313. [PubMed] [Google Scholar]
  8. Mair R. G., McEntee W. J. Cognitive enhancement in Korsakoff's psychosis by clonidine: a comparison with L-dopa and ephedrine. Psychopharmacology (Berl) 1986;88(3):374–380. doi: 10.1007/BF00180841. [DOI] [PubMed] [Google Scholar]
  9. Mair R. G., McEntee W. J., Zatorre R. J. Monoamine activity correlates with psychometric deficits in Korsakoff's disease. Behav Brain Res. 1985 May;15(3):247–254. doi: 10.1016/0166-4328(85)90179-2. [DOI] [PubMed] [Google Scholar]
  10. McEntee W. J., Mair R. G., Langlais P. J. Neurochemical pathology in Korsakoff's psychosis: implications for other cognitive disorders. Neurology. 1984 May;34(5):648–652. doi: 10.1212/wnl.34.5.648. [DOI] [PubMed] [Google Scholar]
  11. McEntee W. J., Mair R. G. Memory enhancement in Korsakoff's psychosis by clonidine: further evidence for a noradrenergic deficit. Ann Neurol. 1980 May;7(5):466–470. doi: 10.1002/ana.410070513. [DOI] [PubMed] [Google Scholar]
  12. McEntee W. J., Mair R. G. Memory impairment in Korsakoff's psychosis: a correlation with brain noradrenergic activity. Science. 1978 Nov 24;202(4370):905–907. doi: 10.1126/science.715450. [DOI] [PubMed] [Google Scholar]
  13. Rinne U. K., Sonninen V. Acid monoamine metabolites in the cerebrospinal fluid of patients with Parkinson's disease. Neurology. 1972 Jan;22(1):62–67. doi: 10.1212/wnl.22.1.62. [DOI] [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES